血管内皮生长因子、白介素-6、同型半胱氨酸在肝硬化及食管胃静脉曲张中的研究进展
Advances in Vascular Endothelial Growth Factor, Interleukin-6 and Homocysteine in Liver Cirrhosis and Gastroesophageal Varices
摘要: 肝硬化是我国常见的慢性疾病，肝硬化患者常常合并门静脉高压，其最主要表现为食管胃静脉曲张(gastroesophageal varices, GOV)，严重威胁患者健康。血管内皮生长因子(vascular endothelial growth factor, VEGF)、白介素-6 (interleukin 6)、同型半胱氨酸(homocysteine, HCY)表达升高与肝硬化患者GOV形成及严重程度密切相关，预测作为评估的新指标，对预后及病情评估有一定价值。本文就VEGF、IL-6、HCY在肝硬化合并胃食管静脉曲张的作用机制、临床评估及未来诊疗展望进行综述。
Abstract: Liver cirrhosis is a common chronic disease in my country, and patients with liver cirrhosis are often associated with portal hypertension, the main manifestation of which is gastroesophageal varices (GOV), which seriously threatens the health of patients. Elevated expressions of vascular endothelial growth factor (VEGF), interleukin-6 (interleukin 6) and homocysteine (HCY) are closely related to the formation and severity of GOV in patients with liver cirrhosis. The new index has certain value for prognosis and disease assessment. This article reviews the mechanism of action of VEGF, IL-6 and HCY in liver cirrhosis complicated with gastroesophageal varices, clinical evaluation and future diagnosis and treatment prospects.
文章引用：但宇慧, 韩文, 李颖. 血管内皮生长因子、白介素-6、同型半胱氨酸在肝硬化及食管胃静脉曲张中的研究进展[J]. 临床医学进展, 2022, 12(2): 1413-1418. https://doi.org/10.12677/ACM.2022.122205

参考文献

[1] 中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425.
[2] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 中华内科杂志, 2016, 55(1): 57-72.
[3] Hwang, J.H., Shergill, A.K., Acosta, R.D., Chandrasekhara, V., Chathadi, K.V., Decker, G.A., et al. (2014) The Role of Endoscopy in the Management of Variceal Hemorrhage. Gastrointestinal Endoscopy, 80, 221-227. [Google Scholar] [CrossRef] [PubMed]
[4] 杨连粤, 白雪莉. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版) [J]. 中国实用外科杂志, 2019, 39(12): 1241-1247.
[5] Iyer, S. and Acharya, K.R. (2011) Tying the Knot: The Cystine Signature and Molecular-Recognition Processes of the Vascular Endothelial Growth Factor Family of Angiogenic Cytokines. The FEBS Journal, 278, 4304-4322. [Google Scholar] [CrossRef] [PubMed]
[6] Melincovici, C.S., Boşca, A.B., Şuşman, S., Mărginean, M., Mihu, C., Istrate, M., et al. (2018) Vascular Endothelial Growth Factor (VEGF)-Key Factor in Normal and Pathological Angiogenesis. Romanian Journal of Morphology and Embryology, 59, 455-467.
[7] Grant, Z.L. and Coultas, L. (2019) Growth Factor Signaling Pathways in Vascular Development and Disease. Growth Factors, 37, 53-67. [Google Scholar] [CrossRef] [PubMed]
[8] Xia, C., Zhu, W., Huang, C., Lou, G., Ye, B., Chen, F., et al. (2020) Genetic Polymorphisms of Interleukin-6 Influence the Development of Hepatitis B Virus-Related Liver Cirrhosis in the Han Chinese Population. Infection, Genetics and Evolution, 84, Article ID: 104331. [Google Scholar] [CrossRef] [PubMed]
[9] Trovato, M., Sciacchitano, S., Facciolà, A., Valenti, A., Visalli, G. and Di Pietro, A. (2021) Interleukin-6 Signalling as a Valuable Cornerstone for Molecular Medicine (Review). International Journal of Molecular Medicine, 47, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
[10] Maron, B.A. and Loscalzo, J. (2006) Homocysteine. Clinics in Laboratory Medicine, 26, 591-609. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, F., Wang, F., He, J., Lian, N., Wang, Z., Shao, J., et al. (2021) Regulation of Hepatic Stellate Cell Contraction and Cirrhotic Portal Hypertension by Wnt/β-Catenin Signalling via Interaction with Gli1. British Journal of Pharmacology, 178, 2246-2265. [Google Scholar] [CrossRef] [PubMed]
[12] Lesmana, C.R.A., Raharjo, M. and Gani, R.A. (2020) Managing Liver Cirrhotic Complications: Overview of Esophageal and Gastric Varices. Clinical and Molecular Hepatology, 26, 444-460. [Google Scholar] [CrossRef] [PubMed]
[13] Hammoutene, A. and Rautou, P. (2019) Role of Liver Sinusoidal Endothelial Cells in Non-Alcoholic Fatty Liver Disease. Journal of Hepatology, 70, 1278-1291. [Google Scholar] [CrossRef] [PubMed]
[14] Poisson, J., Lemoinne, S., Boulanger, C., Durand, F., Moreau, R., Valla, D., et al. (2017) Liver Sinusoidal Endothelial Cells: Physiology and Role in Liver Diseases. Journal of Hepatology, 66, 212-227. [Google Scholar] [CrossRef] [PubMed]
[15] Ferrara, N., Gerber, H.P. and Lecouter, J. (2003) The Biology of VEGF and Its Receptors. Nature Medicine, 9, 669-676. [Google Scholar] [CrossRef] [PubMed]
[16] Fernandez, M., Vizzutti, F., Garcia-Pagan, J.C., Rodes, J. and Bosch, J. (2004) Anti-VEGF Receptor-2 Monoclonal Antibody Prevents Portal-Systemic Collateral Vessel Formation in Portal Hypertensive Mice. Gastroenterology, 126, 886-894. [Google Scholar] [CrossRef] [PubMed]
[17] Calderone, V., Gallego, J., Fernandez-Miranda, G., Garcia-Pras, E., Maillo, C., Berzigotti, A., et al. (2016) Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease. Gastroenterology, 150, 982-997. [Google Scholar] [CrossRef] [PubMed]
[18] Ding, Q., Tian, X.G., Li, Y., Wang, Q.Z. and Zhang, C.Q. (2015) Carvedilol May Attenuate Liver Cirrhosis by Inhibiting Angiogenesis through the VEGF-Src-ERK Signaling Pathway. World Journal of Gastroenterology, 21, 9566-9576. [Google Scholar] [CrossRef] [PubMed]
[19] Remmler, J.S., Bartels, M., Seehofer, D., Scholz, M., et al. (2018) Increased Level of Interleukin 6 Associates with Increased 90-Day and 1-Year Mortality in Patients with End-Stage Liver Disease. Clinical Gastroenterology and Hepatology, 16, 730-737. [Google Scholar] [CrossRef] [PubMed]
[20] Kao, J., Yu, C., Feng, C., Tsai, S.M., Chen, Y.L. and Wu, Y.Y. (2017) IL-6 Significantly Correlates with p-STAT3 Expression and Presents High Variceal Bleeding with Mortality in Cirrhotic Patients: A Cross-Sectional Study. Journal of Microbiology, Immunology and Infection, 50, 286-296. [Google Scholar] [CrossRef] [PubMed]
[21] Xiang, D., Sun, W., Ning, B., Zhou, T.F., Li, X.F., Zhong, W., et al. (2018) The HLF/IL-6/STAT3 Feed Forward Circuit Drives Hepatic Stellate Cell Activation to Promote Liver Fibrosis. Gut, 67, 1704-1715. [Google Scholar] [CrossRef] [PubMed]
[22] Yang, Z., Peng, Y. and Yang, S. (2019) MicroRNA-146a Regulates the Transformation from Liver Fibrosis to Cirrhosis in Patients with Hepatitis B via Interleukin-6. Experimental and Therapeutic Medicine, 17, 4670-4676. [Google Scholar] [CrossRef] [PubMed]
[23] Tung, H., Hsu, S., Tsai, M., Lin, T., Hsin, I., Huo, T., et al. (2017) Homocysteine Deteriorates Intrahepatic Derangement and Portal-Systemic Collaterals in Cirrhotic Rats. Clinical Science, 131, 69-86. [Google Scholar] [CrossRef] 
[24] Maeda, M., Yamamoto, I., Fujio, Y. and Azuma, J. (2003) Homocysteine Induces Vascular Endothelial Growth Factor Expression in Differentiated THP-1 Macrophages. Biochimica et Biophysica Acta (BBA): General Subjects, 1623, 41-46. [Google Scholar] [CrossRef] 
[25] Qi, X., Guo, X., Li, H., Liu, X. and Deng, H. (2016) Knowledge about Non-Invasive Diagnostic Tests for Varices in Liver Cirrhosis: A Questionnaire Survey to the Gastroenterology Branch of the Liaoning Medical Association, China. Gastroenterology Report, 4, 141-147. [Google Scholar] [CrossRef] [PubMed]
[26] Deng, H., Qi, X. and Guo, X. (2015) Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis. Medicine, 94, e1795. [Google Scholar] [CrossRef] 

为你推荐